Publications

The immunopeptidome from a genomic perspective: Establishing the noncanonical landscape of MHC class I–associated peptides
(39 pages) 24 Mar 2023 in Cancer Immunology Research, pp. 1-40
DOI: https://doi.org/10.1158/2326-6066.CIR-22-0621
Research output: Contribution to Journal › Article (E-pub ahead of print)

Project Optimus, an FDA initiative: considerations for cancer drug development internationally, from an academic perspective
3 Mar 2023 in Frontiers in Oncology
DOI: https://doi.org/10.3389/fonc.2023.1144056
Research output: Contribution to Journal › Article (Published)

ARomatase Inhibition plus/minus Src-inhibitor SaracaTinib (AZD0530) in Advanced breast CAncer Therapy (ARISTACAT): a randomised phase II study
2 Mar 2023 in Breast cancer research and treatment
DOI: https://doi.org/10.1007/s10549-023-06873-8
Research output: Contribution to Journal › Article (Published)

Initial active surveillance for patients with metastatic renal cell carcinoma: 10 years' experience at a regional cancer Centre
7 Oct 2022 in Cancer Medicine
DOI: https://doi.org/10.1002/cam4.5330
Research output: Contribution to Journal › Article (Published)

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
30 Aug 2022 in The Lancet Oncology, vol. 23, pp. 1133-1144
DOI: https://doi.org/10.1016/S1470-2045(22)00487-9
Research output: Contribution to Journal › Article (Published)

View all 29 publications on Research Explorer

Data last updated: 05/06/2023 at 12:13